Suven Life Sciences Limited - Asset Resilience Ratio

Latest as of September 2025: 74.12%

Suven Life Sciences Limited (SUVEN) has an Asset Resilience Ratio of 74.12% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs2.50 Billion

≈ $27.04 Million USD Cash + Short-term Investments

Total Assets

Rs3.37 Billion

≈ $36.49 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Suven Life Sciences Limited's Asset Resilience Ratio has changed over time. Check SUVEN strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Suven Life Sciences Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Suven Life Sciences Limited market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs11.77 Million	0.35%
Short-term Investments	Rs2.49 Billion	73.77%
Total Liquid Assets	Rs2.50 Billion	74.12%

Asset Resilience Insights

Very High Liquidity: Suven Life Sciences Limited maintains exceptional liquid asset reserves at 74.12% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Suven Life Sciences Limited Industry Peers by Asset Resilience Ratio

Compare Suven Life Sciences Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Suven Life Sciences Limited (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Suven Life Sciences Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	33.27%	Rs449.79 Million ≈ $4.86 Million	Rs1.35 Billion ≈ $14.62 Million	+6.62pp
2024-03-31	26.65%	Rs759.35 Million ≈ $8.21 Million	Rs2.85 Billion ≈ $30.81 Million	-62.22pp
2023-03-31	88.87%	Rs3.46 Billion ≈ $37.38 Million	Rs3.89 Billion ≈ $42.06 Million	+47.07pp
2022-03-31	41.80%	Rs451.62 Million ≈ $4.88 Million	Rs1.08 Billion ≈ $11.68 Million	-15.76pp
2021-03-31	57.57%	Rs739.26 Million ≈ $7.99 Million	Rs1.28 Billion ≈ $13.89 Million	+57.54pp
2020-03-31	0.03%	Rs494.00K ≈ $5.34K	Rs1.82 Billion ≈ $19.68 Million	-22.29pp
2019-03-31	22.32%	Rs2.32 Billion ≈ $25.08 Million	Rs10.39 Billion ≈ $112.35 Million	-9.43pp
2018-03-31	31.74%	Rs2.90 Billion ≈ $31.36 Million	Rs9.14 Billion ≈ $98.79 Million	-5.20pp
2017-03-31	36.95%	Rs3.01 Billion ≈ $32.59 Million	Rs8.16 Billion ≈ $88.22 Million	+36.94pp
2016-03-31	0.00%	Rs364.00K ≈ $3.94K	Rs7.86 Billion ≈ $84.96 Million	0.00pp
2015-03-31	0.00%	Rs364.00K ≈ $3.94K	Rs7.73 Billion ≈ $83.61 Million	0.00pp
2014-03-31	0.01%	Rs364.00K ≈ $3.94K	Rs4.87 Billion ≈ $52.63 Million	-0.01pp
2013-03-31	0.02%	Rs712.00K ≈ $7.70K	Rs3.34 Billion ≈ $36.13 Million	-1.55pp
2012-03-31	1.57%	Rs44.73 Million ≈ $483.77K	Rs2.85 Billion ≈ $30.82 Million	--

pp = percentage points

About Suven Life Sciences Limited

NSE:SUVEN India Drug Manufacturers - Specialty & Generic

Market Cap

$876.15 Million

Rs81.01 Billion INR

Market Cap Rank

#9377 Global

#474 in India

Share Price

Rs307.20

Change (1 day)

+0.03%

52-Week Range

Rs126.65 - Rs359.55

All Time High

Rs359.55